messenger RNA

Shares in Arbutus Biopharma (NASDAQ:ABUS) soared more than 20% on Wednesday, April 3, after the company received permission to pursue a claim against Moderna Inc (NASDAQ:MRNA) in court. What Happened: Arbutus first filed its patent infringement complaint against Moderna, over the messenger-RNA...

Moderna Inc (NASDAQ: MRNA), a company founded in 2010, is now worth more than the 130-year old Merck & Co., Inc (NYSE: MRK) in terms of market capitalization. What Happened: Moderna’s shares spiked Monday amid a string of positive news including being granted provisional registration...